Search - tctmd.com

Displaying 1 - 20 of 59

Sort: Relevancy | Date

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

Presentation TCT 2016

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Presenter: Oscar A. Mendiz, Giora Weisz, Horst Sievert

October 30, 2016

News Daily News

研究称缺血性心肌病的患者可以受益于心肌卸负荷

Michael O'Riordan

October 17, 2016

News Daily News

Según un Estudio Los Pacientes con Cardiomiopatía Isquémica se Benefician de Descargas Miocárdicas

Michael O'Riordan

October 17, 2016

News Daily News

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Michael O'Riordan

October 17, 2016

News Industry News

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016

News Daily News

Stroke Not the Only Concern in Patients With A-fib

Todd Neale

September 07, 2016

News Conference News ESC 2016

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

Shelley Wood

August 29, 2016

Presentation ESC 2016

Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Heart Failure

Presenter: Javed Butler

August 28, 2016

News Conference News ESC 2016

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

Shelley Wood

August 28, 2016

News Conference News ESC 2016

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Michael O'Riordan

August 28, 2016

News Conference News ESC 2016

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Shelley Wood

August 28, 2016

News Daily News

Less Is Not Always More: Screening for Coronary Disease Underused in Patients With Heart Failure

Todd Neale

July 25, 2016

News Industry News

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

June 27, 2016

News Industry News

BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure with Revivent-TC™ System for Heart Failure Treatment

May 16, 2016

News Industry News

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

April 19, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Conference News ACC 2016

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Michael O'Riordan

April 04, 2016

News Daily News

CAD Extent May Foreshadow Risk of Heart Failure After First MI

L.A. McKeown

March 31, 2016

News Daily News

Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs

Michael O'Riordan

March 25, 2016

Advertisement

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

研究称缺血性心肌病的患者可以受益于心肌卸负荷

Según un Estudio Los Pacientes con Cardiomiopatía Isquémica se Benefician de Descargas Miocárdicas

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

Stroke Not the Only Concern in Patients With A-fib

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Heart Failure

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Less Is Not Always More: Screening for Coronary Disease Underused in Patients With Heart Failure

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure with Revivent-TC™ System for Heart Failure Treatment

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

CAD Extent May Foreshadow Risk of Heart Failure After First MI

Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content